eHealth Inc (EHTH)

RBC Capital has reduced its price target for eHealth Inc. (NASDAQ:EHTH) from $3.00 to $2.00, while maintaining a Sector Perform rating, following the company's Q2 2026 earnings report which showed revenue below estimates. The stock is currently trading near its 52-week low, having declined significantly year-to-date, though an InvestingPro tip suggests it may be undervalued despite burning cash. eHealth is implementing a strategic shift to a lifetime advisory model and reduced marketing spend outside key enrollment periods.

RBC Capital has lowered its price target for eHealth (EHTH) from $3 to $2, while maintaining a Sector Perform rating. This adjustment follows a similar action by Deutsche Bank, which also reduced its price target for eHealth to $2 earlier in the month. The article also mentions recent earnings calls and changes in eHealth's index inclusions.

A new report from eHealth reveals that while most Americans are confident in their Medicare knowledge, many beneficiaries and those approaching eligibility lack crucial understanding of the program's financial risks and complexities. Key findings indicate a widespread unawareness of Original Medicare's 20% cost-sharing, lack of an out-of-pocket maximum, and potential late enrollment penalties. This suggests that consumer confidence does not always equate to actual understanding, potentially leading to significant financial consequences.

A new eHealth survey reveals a significant gap between Medicare beneficiaries' confidence in their understanding of the program and their actual knowledge. While 89% of current beneficiaries feel confident, only 13% can correctly identify all four major Medicare coverage types. The survey highlights widespread unawareness regarding out-of-pocket cost caps, standard 20% cost-sharing, and potential late enrollment penalties for Medicare Part B and Part D.

eHealth (EHTH) has been removed from several Russell Indexes, including the Russell 3000, 2000, and 2500, as well as various value-focused benchmarks. Analysts have updated their price target for eHealth to $2.06 from $2.50, reflecting a higher discount rate, a smaller projected revenue decline, a slightly improved profit margin, and a reduced future P/E multiple. Despite these changes, the stock is currently considered 40.6% undervalued with an intrinsic discount.